GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » 5-Year Yield-on-Cost %

Hisamitsu Pharmaceutical Co (TSE:4530) 5-Year Yield-on-Cost % : 2.06 (As of Dec. 12, 2024)


View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co 5-Year Yield-on-Cost %?

Hisamitsu Pharmaceutical Co's yield on cost for the quarter that ended in Aug. 2024 was 2.06.


The historical rank and industry rank for Hisamitsu Pharmaceutical Co's 5-Year Yield-on-Cost % or its related term are showing as below:

TSE:4530' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.86   Med: 1.7   Max: 2.64
Current: 2.06


During the past 13 years, Hisamitsu Pharmaceutical Co's highest Yield on Cost was 2.64. The lowest was 0.86. And the median was 1.70.


TSE:4530's 5-Year Yield-on-Cost % is ranked worse than
53.74% of 508 companies
in the Drug Manufacturers industry
Industry Median: 2.185 vs TSE:4530: 2.06

Competitive Comparison of Hisamitsu Pharmaceutical Co's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.



Hisamitsu Pharmaceutical Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Hisamitsu Pharmaceutical Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Hisamitsu Pharmaceutical Co  (TSE:4530) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Hisamitsu Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co Headlines

No Headlines